Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I didn't come back to gloat. I was mainly responding to the bowling part. IMO what the FDA is doing to smaller companies such as RVVTF is criminal. I said it back then and I say it now. The FDA fast tracked mRNA vaccines in 6 months when they hadn't worked or been approved for 25 years. And yet a drug such as what RVVTF has,...that has been around forever and proven safe takes years and multiple back and forths to get approval?
It is all a big scam....just like covid was.
And then they have to start a new 3 year trial for the next virus?
Yes, many egos to be satisfied.
Correct. Plus Bucillamine has many uses. That other poster your responded to just came back to gloat btw. Not worth your time.
I should have sold then too Threeflight but if Bucillimine works to degrade the effects of viruses of this type there will be a use for it down the line again even though BP seems to have all the advantages. Rest assured we will have a virus outbreak like covid 19 again.
I actually use 16 pound bowling balls lol. Have around 35 or 40 of them. All brands and types from reactive to urethane. Big fan right now of the Reality and the Venom. Average around 225 in many leagues and tourney's. Am also a PBA pro although not an elite one. Most of the pro's these days use 15 pounds. I like the extra power that extra pound gives me.
As for RVVTF.....I got out a year and a half ago when the covid craze started to die down and I could tell that the FDA was only giving BIG pharma the approval for covid treatments and vaccines. Smaller companies like RVVTF were being shut out from anything. IE.....it's all a scam.
The stock will probably hang around these levels for a while.
According to one of MF's emails, the trial was designed for hospitalization not for symptoms.
So, according to the latest Press Release, "Although the Study was originally designed for a ‘hospitalization or death’ primary endpoint, and it completed enrollment of almost three-quarters of the Study’s recruitment goal and recorded specific clinical symptoms (i.e. cough, fever, heart rate, and oxygen saturation), the Study was not designed to take into account all of the symptom assessments and supporting data outlined in the FDA guidelines to warrant a primary symptom-based endpoint for COVID-19 studies."
Which is why they're unable to pivot to the FDA's recommended primary endpoint. Even though the design was for hospitalization they should have assigned it in order to take in all data points to be more thorough.
I don’t know one way or the other. But could it be experience or lack of that determines success or failure? A BP has the expertise and staff. Or is it fact that small guys don’t have a chance
Sounds like the later is the case here
"He gave examples of other companies that had difficulties trying to get through to the FDA."
The companies he gave as examples were Atea Pharmaceuticals, Appili Therapeutics, CytoDyn, and Humanigen, etc.
Thanks. Interesting how he’s blaming the fda. Plenty folks here had both sides of that coin. They said fda is corrupt while saying also the fda was working with rvv on steps toward approval
I would think if they couldn’t get it done as MF stated then why waste time and money and simply partner or license to a BP?? If they don’t then all hope is lost and the drug isn’t what it seems
Sure this is now option 4 in the PR so maybe one day folks will wake up to a pps above 1.00 with news of some arrangement
Gltu
Since you asked to keep you posted i've had a few email exchanges with Revive (MF). I'm paraphrasing because i never asked for permission to post the entirety of his emails.
From my original email posted here in which i voiced my disappointment with Revive management...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171514727
His reply was that i should speak to and argue with the FDA because they're the governing body. He gave examples of other companies that had difficulties trying to get through to the FDA. And, shareholders knew the risks.
I responded with "A poorly designed clinical trial is not the FDA’s fault, the fault falls on Revive’s management."
In reply MF stated that the trial was designed with hospitalization and the environment changed.
In response i stated that for shareholder's sake i hope Revive has a good plan for moving forward.
His reply was for me to read the Press Releases.
The long haul is over and gone.
Interesting comments in the reddit post Cw..
https://www.reddit.com/r/RVVTF/comments/124lnn4/revive_therapeutics_provides_update_on_psilocybin/?utm_source=share&utm_medium=android_app&utm_name=androidcss&utm_term=1&utm_content=share_button
Ps.still holding to see what happens with Bucillamine of course...
Pps. Rio even commented in there...
Nobody knows the trouble I've seen nobody knows my sorrow........CW thanks for the link,wonder if this will
help share price at all.
Remember this one? How you said it’s no surprise sheep pay a premium to the market
https://seekingalpha.com/news/3924063-revive-therapeutics-close-private-placement
Rug pull
News out on the other side: First patient enrolled.
https://revivethera.com/2023/03/revive-therapeutics-provides-update-on-psilocybin-clinical-study-for-methamphetamine-use-disorder/
Thanks Eco, I'm in for the long haul.
I'm right there with you Classic. Having owned this stock for 2 years I've put more in than I normally do with penny stocks but I guess this has turned into a long term investment rather than a short term one. No reason to dig your own ditch yet, hang in there.....
Yes but there are buy the dippers and some publicly here state so
The non-stop screeching about INVESTORS investing in rvv at these bargain prices is priceless. lololsss
Nobody believes these fake expressions of concern for shareholders are sincere so the act can come to an end.
Too bad, for some, the rabid attempts to create "chaos" has generally failed and likely backfired to some extent.
I wonder what our $25M benefactor Canaccord, and their cohorts have been up to lately!?!?!.............................
Yes but there are buy the dippers and some publicly here state so.
I want the stock to got up to .17 and get me back onto even on 10k shares!
Otherwise there’s a lot of pumping going on and sheep need to be aware.
Put me down for wanting the stock to go up. If this continues, my next ditch to dig may be my own.
ps. Not looking at the stock 50 times a day anymore; I only check it about 15 hoping for a buyout miracle or something to cheer about.
Hedge fund backed MMs prefer that stocks like $RVVTF go to zero, because they sell fake shares, pocket the cash, and if the stock goes to zero they never have to buy back the fake shares (illegal/unreported naked shorts, and short interest). It is also a tool for big business, bug pharma to kill young, limited funding start ups so BF can steal the tech...at fire sales
Flippers world only wants volume and a spread and chaos and mayhem as they drive the share price lower, because they buy more shares for less and drive the stock down to over sold status. The trade mark is "sell as the sky is falling" giberish, typically followed by deliberate bid whacks.
They only win if retail longs let them win.
Everyone wants to be correct but ultimately don't we all just want the stock to go up?
The daily inane posts CONsistently exposes how much an utter fraud ye are.
The motives arent altruistic one bit but rather has an obvious intent, that being to CONvince major retail holders to stampede for the door.
The reason for these efforts?.......time will tell!!!
Sorry plank, while dullard tactics may influence others, screeching non stop outside this window is futile.
Were now witnessing the separation, per say, of the revive Sheep and the Goats..........ie Investors vs Traders.
Eco
Well someone was buying.Hmmmmmmm!
https://www.reddit.com/r/RVVTF/comments/121xidv/request_for_presentation/
If you care to simply put aside at what's being requested, BMT does have some good thoughts on how to proceed forward.
Provide links. I want to hear the crying first hand
Everyone should check out reddit or Facebook revive pages and look at the recent post about getting 5% of the shareholders to ask MF Q & A to clarify our path forward. The reddit it by nick Nintendo and BMT. The Facebook Nick. They are trying to have everyone sign up by this upcoming Thursday.
What fake news? Only fake news I recall is MF telling us he’s moving to NJ back in Sept 2022
Heard a rumor he’s still playing golf in the Bahamas. Dude is screwing shareholder ever day.
Don’t believe put me on ignore.
Well stated ragstorum.
Reliefs OS is huge......over 4.4 BILLION to be clear.
The joker has been throwing this dried crap at the wall trying to make it stick since 2020.
Its as dumb today as it was back then but yet again here it is.
Revive doing an rs now, despite recently raising $4.3M, makes zero sense and even if its done to raise the pps for an uplist, that also is nonsensical since the OS would be reduced to about 2M shares.
OT: On a side note, snpw's current depressed pps after the run to 34s was primarily the result of a court in RI siding with the plaintiffs that opposed the construction of the Medrecycler plant.
The $17M funding for the project was already secured and had the plant been approved the pps would have indeed hit $1+.
Pmpng absolutely did occur but the facts re the project were facts, not just the selective ones ye quoted.
It seems we all trade and have an agenda here.
No problem with that - we make our case to influence others
because it suits our interest. That's trading.
My agenda is to push the science and profit from validated research.
I’ve heard that same argument many times. It just doesn’t hold water over the long term.
Reading recent fake-news-rag lines about RVVTF and the CEO reminds me of the story about the guy that burned down his house using gasoline and a match, and then he blamed the house for the fire, blamed the house not being fireproof LMAO....
LMAO, that is BS, only a fool would R/S a stock with this low of an OS. There are stocks out there on OTC with 40 Bil shares.
1) they will not go to Nasdaq until they succeed with the Bucci/FDA deal.. When that happens the $$$ share price will mean no R?S needed.
2) They just raised 4.3 mil in cash at 0.10 Us dollars/share. Only a fool would do a R/S right now in this market.
Indeed:
"True character is shown in times of adversity.
The ultimate measure of a man is not where he stands in moments of comfort and convenience, but where he stands at times of challenge and controversy.
P.S. RVVTF and Bucillamine. You stood me up, but that's OK. I still think you're hot. "
$RVVTF and the CEO MF are standing tall
Speaking of RVVTF standing us up and being OK because she is hot, I agree
IMO, the folks that invested 4.3 Mil dollars at .10/share US dollars/share for restricted, no liquidity shares, are quietly laughing LTAO, sitting and buying these insurance priced gift shares from the fools of the market place.... selling down here. Would not be surprised if MM's are shorting and wash trading shares to try and pick off weak hands, that is how they make money after all...
"Never seen an offering above current market get concluded and then lose 75% just weeks later "
Not surprised, but because I have a lot more experience in these stocks,.... I have, in fact I helped one raise cash at .21/share in 2014 when the lows had hit .04 and recently, seen it in another Biotech, Athx, that fell from the $1 to $3 range it traded at for 10 years (to .12/share) while burning up cash on multi stem research for decade, 100s of millions....
And it raised 12 Million dollars just after only to get R/S days later and lost another 80% of the share price it raised the $12 Million dollars at and the fell another 70%, only to rally 200% since then, and managed to stay on Nasdaq.
Institutional firm put in the 12 Million dollars, took a huge paper loss, then made a second deal for more shares and warrants..
The last the last 14 months has been brutal to Bio-tech drug start ups, pre revenue, pre-profits.
That is obvous and well know to ones who have been in the market for decades.
I was trading the week the DOW dropped 40% in 3 days in 1987. I made a pile of money buying the knife on day three.....
The said part is I seem to be the only one that sees what is really going with RVVTF.
It has nothing to do with the CEO nurse maiding or not nurse maiding retail share holders.
Yes. That is correct. But I’ve seen plenty of penny stock do it at these o/s levels as well however the lower o/s here does reduce the risk imo!! I read somewhere that MF did do one before in a previous job.
But, compared to Revive (RVVTF) unless i'm wrong RLFTF's outstanding shares are in the billions?
RLFTF just announced they will be doing one. I'll have to lick my wounds on that one when that happens. Dilution always follows. They, like RVVTF, touted a grand covid therapy. That's what these tiny penny stocks do when they need more money to pay their salaries and bonuses. Due to the need to raise funds, the time horizon for making a decent profit with penny stocks is typically very narrow, A few years a ago a wise penny stock investor once posted ---- it's not wise to hold penny stocks that are below a dime with a high o/s for very long, because bad things eventually tend to happen. He is so right!
That will be absolute murder
gov.. High probability that r/s will be next in line. O/S > 320M. JMHO
Did you buy the offering at .15? Nothing reeks scam like that one
Never seen an offering above current market get concluded and then lose 75% just weeks later
True character is shown in times of adversity.
The ultimate measure of a man is not where he stands in moments of comfort and convenience, but where he stands at times of challenge and controversy.
P.S. RVVTF and Bucillamine. You stood me up, but that's OK. I still think you're hot.
Ecomike, you know I have valued many of your posts historically however, I disagree with your response here. That would represent an emotionally-backed stance and reeking of retaliation not to mention borderline vindictive by CEO MF.
CEO Michael Frank, like all good 'leaders' tend to do, should recognize investor sentiment after Monday's dire update and subsequent PPS plunge, and exercise some emotional intelligence at this point by addressing shareholders in a somewhat personalized manner - many of my CEO's do this and it proves effective at the best of times. MF and this whole FDA process has had us all sweating for going on 3 years now and the build-up has resulted in this current toilet-PPS.
Most of us Longs are looking at 80+% paper losses at present. MF needs to give us a status update / strategy to believe in. We merit that to say the least.
His silence stance appears both potentially dodgy and guilty in my opinion (mere speculation based on his action and I hope I am proved otherwise soon). Him communicating with us might effectively eliminate this sentiment, reduce the dumping and increase / encourage new investment.
If MF was confident about Bucillamine and Revive's future, he would and absolutely ought to be vocal about it.
I am an optimist by nature however, the crooked OTCM has screwed me left, right and center these past 18 months - 'hope' is no longer a strategy as an investor and based on his radio silence, hope is all MF is leaving us with currently.
Retail's spinless whining and blaming the $RVVTF CEO for retail's own weak hands, and the US FED's massacre of the banks and stocks and stock markets, just to fix the FED's mistakes is just that, spinless...
Followers
|
339
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
36630
|
Created
|
02/23/17
|
Type
|
Free
|
Moderators Classic Warrior |
Scientific Rationale of Bucillamine
Preclinical and clinical studies have demonstrated that reactive oxygen species contribute to the destruction and programmed cell death of pulmonary epithelial cells.1 N-acetyl-cysteine (NAC) has been shown to significantly attenuate clinical symptoms in respiratory viral infections in animals and humans, primarily via donation of thiols to restore antioxidant and to reduce the activity of cellular glutathione 2,3,4,5. Bucillamine (N-(mercapto-2-methylpropionyl)-l-cysteine) has a well-known safety profile and is prescribed in the treatment of rheumatoid arthritis in Japan and South Korea for over 30 years. Bucillamine, a cysteine derivative with two thiol groups, has been shown to be 16 times more potent as a thiol donor in vivo than NAC 6. The drug is non-toxic with high cellular permeability. The basis of the clinical study will analyze if Bucillamine has the potential, via restoration of glutathione activity and other anti-inflammatory activity, to lessen the negative consequences of SARS-CoV2 infection in the lungs.
| Psilocin Pharma Corp. has developed production solutions for the active compound Psilocybin. Our process encompassed with our intellectual property cover methods of production of Psilocybin based formulations. Psilocin Pharma Corp’s range of products have been engineered to work synergistically with the body's own natural pathways of absorption while offering a contemporary approach to consumption. Psilocin Pharma also has strong relationships with specific lab partners in certain areas like Brazil, where these formulations are legally approved and plan to sell products in these jurisdictions. | |
| |
Mental Health (Depression, PTSD & Anxiety)
|
Supplements for Brain Health & Cognitive Enhancement
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |